Skip to content

Registration for 2024 Annual Ataxia Conference is NOW OPEN! Early-bird discount available for a limited time.  LEARN MORE!

Neurobooth: A study of motor behavior using digital technologies

Neurobooth: A study of motor behavior using digital technologies

The purpose of this study is to create new digital tools to measure speech, movement, and cognition in people with and without neurological diseases. Our goal is to improve the accuracy of diagnosis and the ability to discover effective treatments.

Link to enroll: neurobooth.mgh.harvard.edu

About the Study

Eligible Ataxia Types
All Ataxias

Type of Study
Research Study

Clinical Trial Phase
N/A

Age Range
Adult 18+

Study Start Date
04/2022

Estimated Completion Date
N/A – Ongoing

IRB Approval #
2021P000257

Location(s)

Massachusetts General Hospital
15 Parkman Street
Boston, MA

Contact Information

Neurobooth Study Team
neurobooth@mgh.harvard.edu
Phone: 857-238-1520

What does participation in the study entail?

Participants will be guided through a 40-minute assessment that will measure their motor skills, eye movements, speech, and thinking using cameras and a microphone. During this time, participants will complete tasks on a computer and wear sensors on their bodies.

What are the potential benefits for participants?

There are no direct benefits, but your participation will help create new technologies to diagnose and measure neurological diseases and support the development of new treatments.

What are the potential risks for participants?

Potential risks could include loss of confidentiality and anxiety during the assessment.

Is there financial compensation?

Yes. $25 Amazon Gift Card.

Is there travel reimbursement?

No.

Who is eligible?

People who are willing to travel to Boston for the in-person assessment, have a known or possible neurologic condition, have a family history of ataxia, are healthy individuals, and are at least 14 years of age. People with and without symptoms are eligible. We want to develop tools that can detect and measure the earliest signs of ataxia.

View Other Research Opportunities

PRIME-Ataxia RCT

This study aims to determine the feasibility and efficacy of an 8-week remote intervention of high intensity aerobic exercise prior to balance training compared to an 8-week remote intervention low Read More…

Print Friendly, PDF & Email
Read More »
Print Friendly, PDF & Email

The purpose of this study is to create new digital tools to measure speech, movement, and cognition in people with and without neurological diseases. Our goal is to improve the accuracy of diagnosis and the ability to discover effective treatments.

Link to enroll: neurobooth.mgh.harvard.edu

About the Study

Eligible Ataxia Types
All Ataxias

Type of Study
Research Study

Clinical Trial Phase
N/A

Age Range
Adult 18+

Study Start Date
04/2022

Estimated Completion Date
N/A – Ongoing

IRB Approval #
2021P000257

Location(s)

Massachusetts General Hospital
15 Parkman Street
Boston, MA

Contact Information

Neurobooth Study Team
neurobooth@mgh.harvard.edu
Phone: 857-238-1520

What does participation in the study entail?

Participants will be guided through a 40-minute assessment that will measure their motor skills, eye movements, speech, and thinking using cameras and a microphone. During this time, participants will complete tasks on a computer and wear sensors on their bodies.

What are the potential benefits for participants?

There are no direct benefits, but your participation will help create new technologies to diagnose and measure neurological diseases and support the development of new treatments.

What are the potential risks for participants?

Potential risks could include loss of confidentiality and anxiety during the assessment.

Is there financial compensation?

Yes. $25 Amazon Gift Card.

Is there travel reimbursement?

No.

Who is eligible?

People who are willing to travel to Boston for the in-person assessment, have a known or possible neurologic condition, have a family history of ataxia, are healthy individuals, and are at least 14 years of age. People with and without symptoms are eligible. We want to develop tools that can detect and measure the earliest signs of ataxia.

View Other Research Opportunities

PRIME-Ataxia RCT

This study aims to determine the feasibility and efficacy of an 8-week remote intervention of high intensity aerobic exercise prior to balance training compared to an 8-week remote intervention low Read More…

Print Friendly, PDF & Email
Read More »
Print Friendly, PDF & Email
Translate »

Join the Ataxia community today!

Become a free member for exclusive content from NAF.